Details for New Drug Application (NDA): 202880
✉ Email this page to a colleague
The generic ingredient in ZOHYDRO ER is hydrocodone bitartrate. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
Summary for 202880
Tradename: | ZOHYDRO ER |
Applicant: | Recro Gainesville |
Ingredient: | hydrocodone bitartrate |
Patents: | 16 |
Medical Subject Heading (MeSH) Categories for 202880
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
Approval Date: | Oct 25, 2013 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 25, 2033 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF PAIN IN PATIENTS WITH HEPATIC IMPAIRMENT | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 12, 2034 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF PAIN | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 25, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 202880
Complete Access Available with Subscription